Well Lead Medical (Well Lead) in China has awarded a new contract to Bactiguard, a Sweden-based meditech company.
It was reported on Friday that the order is to generate revenues of around SEK16.5m in the fourth quarter of 2019.
Christian Kinch, CEO, stated: "This is the second order from Well Lead outside the initial contract and further strengthens that end-customer sales in China are picking up. At the same, we don't expect to receive any new orders from Well Lead in the beginning of next year, given the high volumes delivered in the third and fourth quarters of this year."
Inspiration Healthcare secures US purchasing agreement to drive Airon growth
West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m
Citius Pharmaceuticals reports full-year financial results
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
Amgen announces Q1 2026 dividend
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera